Click on image to open expanded view
Item No.
10191
You May Also Like
Product Description
Chondroprotec Sterile Solution is a sterile solution that uses PSGAG (polysulfated glycosaminoglycan) to treat and manage traumatic injury, surgical incisions, second degree burns, first degree burns, bleeding dermal lesions, secreting dermal lesions (in horses), and full or partial thickness wounds.
Who is Chondroprotec 10 ml for?
Horses, cats and dogs.
Why use Chondroprotec 10 ml?
Chondroprotec is useful in treating: Venous stasis ulcers Donor sites Surgical incisions Stage I to Stage IV pressure ulcers 2nd-degree burns 1st-degree burns Bleeding dermal lesions Secreting dermal lesions Full-thickness wounds Partial-thickness wounds
How does Chondroprotec 10 ml work?
PSGAGs (polysulfated glycosaminoglycans) are useful in treating degenerative and arthritic joint conditions that aren't caused by infection. They can also be used to treat joint injuries and the lameness that often results from them.
Manufacturer:
Neogen Corporation
Active Ingredients(s):
Each 10 ml contains 1000 mg polysulfated glycosaminoglycan ( PSGAG )
How is Chondroprotec 10 ml sold?
1000 mg/10 mL vial
What are the side effects of Chondroprotec 10 ml?
Not for use as a permanent or long-term dressing.
What special precautions are there?
Not for use in animals slated for human consumption. Only administer to horses, cats, and dogs.
What to do if overdose?
If overdose occurs, please contact your local pet hospital or emergency pet clinic immediately.
How can I store Chondroprotec 10 ml?
Keep stored in a cool and dry environment. Discard any unused portions.
Overview
1) Irrigate the wound with sterile water or regular saline. 2) Withdraw the solution with a syringe or pour the contents of the vial over the affected area, completely covering the wound. 3) Apply Chondroprotec liberally to the wound's surface. 4) Cover the wound with gauze or a telfa (non-stick) pad. 5) Reapply daily as needed and redress the wound location every 5 to 7 days. Chondroprotec injections may be given through the wound dressing in the future. This will keep the wound bed from being disturbed.
Main Ingredients
Polysulfated Glycosaminoglycan 1000 mg of PSGAG in a 10 mL vial (100 mg/mL) Derived from bovine trachea Preservative free
